By Ben Butkus

Thermo Fisher's $260 million planned acquisition of molecular biology research tool shop Fermentas, announced last week, will undoubtedly strengthen Thermo Fisher's rapidly expanding portfolio of PCR research products as it looks to compete on that front with rivals such as Life Technologies, Qiagen, and Sigma-Aldrich.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.